NCT07057037View on ClinicalTrials.gov

Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases

PHASE3RecruitingINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

August 31, 2026

Conditions
Rotator Cuff TearLabral TearRotator Cuff TendinosisRotator Cuff TendonitisArticular Cartilage InjuryGlenohumeral LigamentLong Head Biceps Tendon TearAdhesive Capsulitis
Interventions
DRUG

NEMO-103 Injection

15mL(at least 12mL), solution for Intravenous injection, single dose

Trial Locations (8)

5505

RECRUITING

Asan Medical Center, Seoul

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

0308

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

05030

RECRUITING

Konkuk University Medical Center, Seoul

06273

RECRUITING

Gangnam Severance Hospital, Seoul

06591

RECRUITING

The Catholic University of Korea Seoul ST. Mary's Hospital, Seoul

08308

RECRUITING

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Inventera Inc.

INDUSTRY